
235.85 Delayed Data As of May 20 | ![]() Today’s Change | 226.46 Today|||52-Week Range 379.30 | -34.33% Year-to-Date |
Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio For Now May 16 / Zacks.com - Paid Partner Content | Why Abiomed (ABMD) is a Top Growth Stock for the Long-Term May 12 / Zacks.com - Paid Partner Content |
Previous close | 238.65 |
Today’s open | 241.19 |
Day’s range | 226.69 - 241.19 |
Volume | 32,017 |
Average volume (3 months) | 366,146 |
Market cap | $10.7B |
Earnings growth (last year) | -39.88% |
Earnings growth (this year) | +2.34% |
Earnings growth (next 5 years) | +16.37% |
Revenue growth (last year) | +21.74% |
P/E ratio | 81.0 |
Price/Sales | 14.73 |
Price/Book | 7.14 |
Today’s change | Today’s % change | |
---|---|---|
TFXTeleflex Inc | -1.70 | -0.59% |
PODDInsulet Corp | +3.89 | +2.00% |
---- | ||
SWAVShockwave Medical In... | -1.95 | -1.22% |
Next reporting date | July 28, 2022 |
EPS forecast (this quarter) | $1.05 |
Annual revenue (last year) | $1.0B |
Annual profit (last year) | $136.5M |
Net profit margin | 13.23% |
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Danvers, Massachusetts |